We then performed bioanalytical measurements of exatecan in tumor versus bone marrow after dosing equimolar amounts of either CBX-12 or unconjugated exatecan in vitro and in vivo, and we compared these data to TOP1 protein levels in the corresponding samples. The gene discussed is TOP1; the disease is neoplasm.